News
The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it.
The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...
Health Secretary Robert F. Kennedy Jr. has repeatedly questioned the safety of mRNA technology, which is used in the ...
NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.
5h
Tampa Free Press on MSNFDA Approves Moderna’s Next-Gen COVID-19 Vaccine For High-Risk GroupsThe Food and Drug Administration (FDA) has approved Moderna's next-generation COVID-19 vaccine, mNEXSPIKE, for specific ...
The Trump administration has canceled $766 million awarded to drugmaker Moderna Inc. to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu. The company ...
Moderna said Wednesday that an early-phase trial of its mRNA-based vaccine against H5 bird flu in about 300 healthy adults showed “a rapid, potent and durable immune response.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results